OpenVSafe by OpenVAERS
Search V-safe

2GU-20286-70165

2 vaccinations 6 coded responses 19 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
51-55
ZIP prefix
400 / KY
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Moderna
  3. 2021-03-24
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  6. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  10. 2021-03-31
    Health check-in — day 7, dose 1
    Feeling: Fair · Joint pains, Fatigue or tiredness
    Adult check-in
  11. 2021-04-07
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling, Injection site warmth — Feeling: Fair
    Free text: Redness, swelling, warm to the touch, and itchy at the injection site a few day's ago. It lasted 2 day's. Today still warm to the touch, and I can still feel a lump.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-14
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-21
    Dose 2 — Moderna
  14. 2021-04-21
    Survey response — day 0, dose 2
    MedDRA: Dizziness, Tremor — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Lightheaded, shakey
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lightheaded, and dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Pain in extremity — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Legs hurting, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  18. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  19. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  20. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  21. 2021-10-20
    Survey response — 6 months, dose 2
    MedDRA: Atrial fibrillation, Graves' disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I have developed a fib, and diagnosed with graves disease. My quality of life has dramatically been affected.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-04-21
    Survey response — 12 months, dose 2
    MedDRA: Alopecia, Asthenia, Atrial fibrillation, Back pain, Dyspnoea, Endocrine ophthalmopathy, Graves' disease, Headache, Pain in extremity, Quality of life decreased, Skin disorder, Sleep disorder, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Afib, graves disease, thyroid eye disease, excruciating pain in legs and back, headaches, weakness, tremors, no energy, hairloss, skin and scalp issues, Shortness of breath, sleeping issues, My quality of life has been affected severely.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-04-21
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  24. 2022-04-22

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Moderna
22021-04-21Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-07

Symptoms: Redness, swelling, warm to the touch, and itchy at the injection site a few day's ago. It lasted 2 day's. Today still warm to the touch, and I can still feel a lump.

Release 7 — day 0, dose 2

2021-04-21

Systemic reaction (other): Lightheaded, shakey

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Lightheaded, and dizziness

2021-04-23

Systemic reaction (other): Legs hurting, dizziness

Release 10 — 6 months, dose 2

2021-10-20

Symptoms: I have developed a fib, and diagnosed with graves disease. My quality of life has dramatically been affected.

Release 11 — 12 months, dose 2

2022-04-21

Symptoms: Afib, graves disease, thyroid eye disease, excruciating pain in legs and back, headaches, weakness, tremors, no energy, hairloss, skin and scalp issues, Shortness of breath, sleeping issues, My quality of life has been affected severely.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAlopecia · · ✓
SDAsthenia · · ✓
SDAtrial fibrillation · · ✓
SDBack pain · · ✓
SDDyspnoea · · ✓
SDEndocrine ophthalmopathy · · ✓
SDGraves' disease · · ✓
SDHeadache · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site mass ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SDPain in extremity · · ✓
SDQuality of life decreased · · ✓
SDSkin disorder · · ✓
SDSleep disorder · · ✓
SDTremor · · ✓
SRODizziness ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROTremor ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release